All of these findings indicate that the phenotype of Th17 cells in B-CLL patients is different from that in healthy subjects, presenting greater concentrations of IL-17F, and that lymphocytes from B-CLL patients are intensely reactive to IL-17F compared to healthy subjects [166]. This evidence concerns the gene IL17F and B-cell chronic lymphocytic leukemia.